Cytoblastin 10 mg (Vinblastine Sulphate) Quantity:3 Injection/s the most common of which

the most common of which include hand‑foot skin reaction

Muscle tightness after physical exertion

a globally recognized manufacturer with a strong track record in HIV therapy

Obesema 1mg Injection Intermediate Tier: Review the intermediate maintenance pre-filled pen by Alkem Laboratories if you need to check previous titration steps

reducing the risk of stroke

Cytoblastin 10 mg (Vinblastine Sulphate) Quantity:3 Injection/s the most common of whichProduct Overview \nCytoblastin 10 mg is a sterile injectable formulation containing vinblastine sulphate, a potent microtubuledestabilizing agent classified as a vinca alkaloid. Manufactured by Cipla Limited, the medication is supplied in a singleuse vial containing 10 ml of solution intended for intravenous administration. The drug is indicated for the treatment of several solid tumours, most notably breast cancer, renal cell carcinoma, and Hodgkins